13
Participants
Start Date
September 30, 2011
Primary Completion Date
May 31, 2015
Dexamethasone
Given PO or IV
Laboratory Biomarker Analysis
Correlative studies
Methotrexate
Given IT
Mitoxantrone Hydrochloride
Given IV
Pegaspargase
Given IV
Pharmacological Study
Correlative studies
Temsirolimus
Given IV
Vincristine Sulfate
Given IV
Columbia University Medical Center, New York
Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Children's Hospital of Philadelphia, Philadelphia
Children's National Medical Center, Washington D.C.
University of North Carolina at Chapel Hill, Chapel Hill
Children's Healthcare of Atlanta - Egleston, Atlanta
Children's Hospital of Alabama, Birmingham
Vanderbilt University/Ingram Cancer Center, Nashville
University of Mississippi Medical Center, Jackson
Nationwide Children's Hospital, Columbus
Rainbow Babies and Childrens Hospital, Cleveland
Cincinnati Children's Hospital Medical Center, Cincinnati
Riley Hospital for Children, Indianapolis
C S Mott Children's Hospital, Ann Arbor
Midwest Children's Cancer Center, Milwaukee
Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
University of Minnesota Medical Center-Fairview, Minneapolis
Lurie Children's Hospital-Chicago, Chicago
Washington University School of Medicine, St Louis
The Childrens Mercy Hospital, Kansas City
University of Oklahoma Health Sciences Center, Oklahoma City
UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Baylor College of Medicine, Houston
Primary Children's Hospital, Salt Lake City
Phoenix Childrens Hospital, Phoenix
Rady Children's Hospital - San Diego, San Diego
Childrens Hospital of Orange County, Orange
UCSF Medical Center-Parnassus, San Francisco
Lucile Packard Children's Hospital Stanford University, Palo Alto
Oregon Health and Science University, Portland
Hospital for Sick Children, Toronto
National Cancer Institute (NCI)
NIH